Influence of luminal stenosis in aneurysmal and non-aneurysmal blunt cerebrovascular injury
Introduction
In high grade blunt cerebrovascular injury (BCVI), rates of stroke can be substantial with stroke frequently responsible for patient mortality [1,2]. Pharmacologic therapy with antiplatelet agents or anticoagulation and early BCVI diagnosis decrease stroke rates [[3], [4], [5]]. Focus is placed on rapid screening and initiation of pharmacologic therapy to prevent strokes. Pharmacologic and endovascular BCVI treatment are chosen based on BCVI grade, which stratifies BCVI from 1 to 5 based on radiographic characteristics [6].
As BCVI grade increases so does morbidity, with higher BCVI grade associated with higher stroke rates [1,7]. However, there are many lesion characteristics which comprise BCVI, including degree of luminal stenosis (LS), intraluminal thrombus, intimal flap, and arteriovenous fistula. The presence of pseudoaneurysm (PSA) confounds the grading scale as well. It is difficult to encompass pathophysiology this complex into a watertight grading scale.
The influence of LS on stroke formation is mostly unknown. LS is only grossly differentiated between grade 1 BCVI (< 25% LS), grade 2 BCVI (≥ 25% LS and ≤ 99% LS) and grade 4 BCVI (100% LS or complete vessel occlusion) within the currently used BCVI grading scale. There is no differentiation for LS in grade 3 BCVI, with grade 3 BCVI comprising all degrees of LS with PSA. In chronic carotid stenosis higher degree of LS is associated with need for intervention to decrease stroke risk, and similar principles may hold true in BCVI [8]. For example in BCVI, a 30% LS is a grade 2 injury just as 90% LS is a grade 2 injury, but these BCVI are unlikely to have the same risk of stroke.
The primary aim of this study was to investigate the association between LS and rates of stroke formation for both aneurysmal and non-aneurysmal disease. We hypothesized that higher degree of LS beyond the currently used BCVI grading scale would be associated with higher rates of stroke.
Section snippets
Materials and methods
Institutional Review Board (IRB) approval was obtained from the University of Maryland School of Medicine. A single-institution retrospective review of BCVI was undertaken from 2012-2014. BCVI were included if the first computerized tomography (CT) scan diagnosed a BCVI, and excluded if BCVI diagnosis was initially seen on a subsequent CT. Multiple BCVI in a single patient were considered separate BCVI.
BCVI were graded with the current BCVI grading scale of 1, 2, 3, 4, or 5 [6] (Fig. 1). The
Results
Overall 312 BCVI were included, with 140 carotid BCVI and 172 vertebral BCVI. Injury severity score (ISS), diastolic blood pressure, systolic blood pressure, and heart rate were all normally distributed for both carotid and vertebral BCVI, allowing for assessment of means and standard deviations. Overall 24/312 (8%) of BCVI had a stroke and 2/312 (1%) had stroke-related mortality. Stroke was present on admission in 7/312 (2%) BCVI. 16/312 (5%) BCVI underwent EI.
In carotid BCVI, gender
Discussion
The BCVI grading scale has previously shown increasing BCVI severity with higher grade [1,7]. However, multiple factors in BCVI grading make true stroke risk with LS difficult to measure. Foremost, EI may lower stroke risk by preventing strokes which otherwise would have occurred. Similarly grade 3 BCVI represents PSA with all degrees of LS and grade 2 BCVI represents ≥25% and ≤99% LS, which may hide influence of higher degrees of LS on stroke formation given these broad ranges. By accounting
Conclusion
LS seems to influence stroke formation beyond the current BCVI grades. Appropriate use of EI may cloud ability to detect the full influence of LS on stroke development, as we often used EI in BCVI with higher percentage LS. This is especially true in grade 3 BCVI with combined LS and PSA, which appear to be a high-risk subgroup. Trauma practitioners should be aware of BCVI characteristics beyond the grading scale to adequately determine risk for each individual BCVI.
Meeting presentations
None.
Acknowledgements
There was no funding used for this project.
References (21)
- et al.
Initial screening test for blunt cerebrovascular injury: validity assessment of whole-body computed tomography
Surgery
(2015) - et al.
Expanded screening criteria for blunt cerebrovascular injury: a bigger impact than anticipated
Am J Surg
(2016) - et al.
Endovascular stenting is rarely necessary for the management of blunt cerebrovascular injuries
J Am Coll Surg
(2014) - et al.
Blunt cerebrovascular injuries: does treatment always matter?
J Trauma
(2009) - et al.
Lethal now or lethal later: the natural history of grade 4 blunt cerebrovascular injury
J Trauma Acute Care Surg
(2015) - et al.
Blunt cerebrovascular injuries: diagnosis and treatment
J Trauma
(2001) - et al.
Anticoagulation is the gold standard therapy for blunt carotid injuries to reduce stroke rate
Arch Surg
(2004) - et al.
CTA-based screening reduces time to diagnosis and stroke rate in blunt cervical vascular injury
J Trauma
(2009) - et al.
Blunt carotid arterial injuries: implications of a new grading scale
J Trauma
(1999) - et al.
Treatment-related outcomes from blunt cerebrovascular injuries: importance of routine follow-up arteriography
Ann Surg
(2002)